[HTML][HTML] Etiology, epidemiology, pathophysiology and management of tricuspid regurgitation: an overview

F Condello, M Gitto, GG Stefanini - Reviews in Cardiovascular …, 2021 - imrpress.com
Significant tricuspid regurgitation (TR) is a common finding, affecting about one in twenty-
five subjects among the elderly and presenting more frequently in women than in men. This …

Impact of right ventricular dysfunction on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation

N Karam, L Stolz, M Orban, S Deseive, F Praz… - Cardiovascular …, 2021 - jacc.org
Objectives This study sought to assess the impact of right ventricular dysfunction (RVD) as
defined by impaired right ventricular-to-pulmonary artery (RV-PA) coupling, on survival after …

Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock

T Simard, S Vemulapalli, RG Jung, A Vekstein… - Journal of the American …, 2022 - jacc.org
Background Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients
with cardiogenic shock (CS) are limited. Objectives This study investigated the …

Tricuspid regurgitation in left ventricular systolic dysfunction: marker or target?

D Margonato, F Ancona, G Ingallina… - Frontiers in …, 2021 - frontiersin.org
Far from being historically considered a primary healthcare problem, tricuspid regurgitation
(TR) has recently gained much attention from the scientific community. In fact, in the last …

Real-world outcomes of fourth-generation mitral transcatheter repair: 30-day results from EXPAND G4

RS von Bardeleben, JH Rogers, P Mahoney… - Cardiovascular …, 2023 - jacc.org
Abstract Background The fourth-generation MitraClip G4 System builds on the previous
NTR/XTR system with additional wider clip sizes (NTW and XTW), an independent grasping …

[HTML][HTML] Mitral valve transcatheter edge-to-edge repair

J Hausleiter, TJ Stocker, M Adamo… - …, 2023 - eurointervention.pcronline.com
Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, results in reduced quality of life, heart failure, and increased mortality. Mitral valve …

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score

N Shah, MV Madhavan, WA Gray, SJ Brener… - Cardiovascular …, 2022 - jacc.org
Background There are limited data on the predictors of death or heart failure hospitalization
(HFH) in patients with heart failure (HF) with functional mitral regurgitation (FMR). Objectives …

Redo surgical mitral valve replacement versus transcatheter mitral valve in valve from the national inpatient sample

M Zia Khan, S Zahid, MU Khan, A Kichloo… - Journal of the …, 2021 - Am Heart Assoc
Background Redo mitral valve surgery is required in up to one‐third of patients and is
associated with significant mortality and morbidity. Valve‐in‐valve transcatheter mitral valve …

Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality

M Adamo, M Pagnesi, G Ghizzoni… - European Journal of …, 2022 - Wiley Online Library
Aim To evaluate short‐term changes in tricuspid regurgitation (TR) after transcatheter edge‐
to‐edge mitral valve repair (M‐TEER) in secondary mitral regurgitation (SMR), their …

Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial

N Beohar, G Ailawadi, LN Kotinkaduwa… - European heart …, 2022 - academic.oup.com
Aims Baseline renal dysfunction (RD) adversely impacts outcomes among patients with
heart failure (HF) and severe secondary mitral regurgitation (MR). Heart failure and MR, in …